Table 4 Relative odds ratios (OR) and 95 % confidence intervals (CI) for having chronic vulvar pain by log-transformed serum hormone levels at Visit 12 among women not using hormones
From: Chronic vulvar pain in a cohort of post-menopausal women: Atrophy or Vulvodynia?
Hormone (log) | Unadjusted Model | Adjusted Model* | ||
|---|---|---|---|---|
Current Chronic Vulvar Pain vs none | Past/Short-term Chronic Pain vs none | Current Chronic Vulvar Pain vs none | Past/Short-term Vulvar Pain vs none | |
OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | |
Visit 12 (N = 319) | ||||
E2 (average, pg/mL) | 0.49 (0.28, 0.86)** | 1.37 (0.86, 2.19) | 0.58 (0.32, 1.04) | 1.52 (0.92, 2.50) |
DHEA-S (ug/dL) | 0.46 (0.29, 0.75) *** | 1.09 (0.69, 1.73) | 0.45 (0.28, 0.72)*** | 1.07 (0.66, 1.74) |
FSH (mIU/mL) | 1.13 (0.39, 3.28) | 1.11 (0.60, 2.05) | 0.76 (0.28, 2.10) | 1.15 (0.56, 2.39) |
SHBG (nM) | 1.45 (0.49, 4.31) | 0.99 (0.52, 1.89) | 1.00 (0.29, 3.47) | 0.99 (0.47, 2.11) |
T (ng/dL) | 0.13 (0.04, 0.48) *** | 1.38 (0.55, 3.47) | 0.14 (0.04, 0.56)*** | 1.39 (0.53, 3.68) |